|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 229.94 USD | -9.05% |
|
-9.06% | -4.54% |
| 10-30 | RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating | MT |
| 10-30 | Citigroup Adjusts Price Target on ResMed to $270 From $240 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RESMED, INC. | Other Advanced Medical Equipment & Technology | -9.05% | -9.06% | -4.54% | -8.85% | -12.54% | 35.56B |  |  | |
- Stock Market
- Stocks
- RMD Stock
- Charts ResMed, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
